Skip Navigation

ACS is committed to helping combat the global COVID-19 pandemic with initiatives and free resources. Learn More

Peter Wuelfing

Peter Wuelfing

Pete Wuelfing has had various roles across Pharmaceutical Sciences at Merck since 2001 spanning the discovery /development interface as well as late stage formulation/analytical development.  He is currently the executive director of a team executing in the discovery Pharmaceutics / preformulation space.  His research interests include formulation design for and drug absorption in preclinical species.